期刊文献+

西达本胺的工艺优化 被引量:4

Process Optimization of Chidamide
原文传递
导出
摘要 (E)-3-(3-吡啶)丙烯酸经羰基二咪唑活化生成活泼中间体(E)-3-(3-毗啶)丙烯酰咪唑(3)后,与4-氨甲基苯甲酸的钠盐在水和二氯甲烷的混合溶剂中经相转移催化反应得4-[N-[(E)-3-(3-吡啶)丙烯酰基]氨甲基]苯甲酸(5),避免了3遇水分解,将收率从62%提高至80%。5与3,4-二氨基氟苯在N,N'-二环己基碳二亚胺和催化量的1-羟基苯并三唑作用下缩合得西达本胺,将间位杂质降至5%以内,粗品经乙醇重结晶后纯度达99.5%,总收率61.5%。 4-[N-[(E)-3-(3-Pyridin)acroloyl]amidomethyl]benzoic acid(5) was synthesized via a phase transfer catalysis reaction of 4-amidomethyl benzoate sodium and (E)-3-(3-pyridin)acroloyl imidazole(3) which was prepared from (E)-3-(3-pyridin)acrylic acid in a mixed solvent of dichloromethane and water, the decomposition of 3 could be avoided and the yield was increased from 62% to 80% . Then 5 reacted with 3,4-diaminofluorobenzene in the presence of dicyclohexylcarbodiimide and 1-hydroxybenzotriazole followed by recrystallization from ethanol to afford chidamide with an overall yield of 61.5% and a purity of 99.5% .
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2017年第7期994-996,共3页 Chinese Journal of Pharmaceuticals
关键词 西达本胺 组蛋白脱乙酰酶抑制剂 相转移催化反应 工艺优化 chidamide histone deacetylase inhibitor phase transfer catalysis reaction process optimization
  • 相关文献

参考文献2

二级参考文献8

  • 1[1]Pazin MJ, Kadonaga JT. What' s Up and Down with Histone Deacetylation and Transcription [ J ]. Cell, 1997,89 (2): 325 - 328.
  • 2[2]Saito A, Yamashita T, Mariko Y, et al. A synthetic inhibitor of histone deacetylase,MS-27-275,with marked in vivo antitumor activity against human tumors [ J ]. PNAS, 1999, 96 ( 8 ): 4592 -4597.
  • 3[3]Lu XP, Li ZB, Xie AH, et al. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and antiproliferation activity[P]. US P: US60/447915,2003 - 03 - 28.
  • 4[4]Silvio M,Antonello M,Gianluca S, et al. 3-(4-Aroyl-1 H-pyrrol2-yl)-N-hydroxy -2-propenamides, a new class of synthetic histone deacetylase inhibitors [ J ]. J Med Chem, 2001,44 ( 13 ):2069 - 2072.
  • 5[5]Tsuneji S,Tomoyuki A,Katsutoshi T,et al. Method of producing benzamide derivatives[ P]. EP:0 974 576 A2,2000- 01 -26.
  • 6李小秋,李甘地,高子芬,周小鸽,朱雄增.中国淋巴瘤亚型分布:国内多中心性病例10002例分析[J].诊断学理论与实践,2012,11(2):111-115. 被引量:248
  • 7刘隽,唐勇,程毅敏,姚一芸,邹丽芳,汪蕾,朱琦.培门冬酶联合地塞米松治疗老年进展期结外NK/T细胞淋巴瘤的临床研究[J].中国癌症杂志,2013,23(4):298-301. 被引量:12
  • 8马军,吴一龙,秦叔逵,季加孚,石远凯,孙燕,廖美琳,管忠震,沈志祥.肿瘤相关静脉血栓栓塞症的预防与治疗中国专家指南(2015版)[J].中国肿瘤临床,2015,42(20):979-991. 被引量:175

共引文献22

同被引文献24

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部